Prognostic role of elevated platelet count in patients with lung cancer: a systematic review and meta-analysis.
Authors:
- 15 April 2015
- journal article
- Vol. 8 (4) , 5379-87
Abstract
Recently, more and more studies have shown that platelet count (PLT) may be associated with the prognosis of lung cancer (LC). However, the prognostic role of PLT in lung cancer is still controversial. In the present study, we conducted a meta-analysis of all available English studies to evaluate the prognostic value of PLT in lung cancer. In order to investigate the association between PLT and overall survival (OS), the hazard ratio (HR) and its 95% confidence interval (CI) was evaluated. The odds ratio (OR) with its 95% confidence interval (CI) was used to assess the relationship between PLT and clinicopathological parameters. There were 12 studies (n = 5,884) were involved in this meta-analysis. The pooled results showed that elevated PLT was a negative predictor for OS and the pooled HRs was significant at 1.74 (95% confidence interval, 1.39-2.19). Elevated PLT was also significantly associated with advanced TNM stage (OR: 2.65, 95% CI: 1.77-3.97) and smoking history (OR: 2.70, 95% CI: 1.79-4.08). In addition, there was no significant correlation between elevated PLT and squamous cell carcinoma (OR: 1.54, 95% CI: 0.77-3.07). Our results demonstrated that elevated PLT denotes a poor prognosis in patients with LC.Keywords
This publication has 40 references indexed in Scilit:
- Prognostic Significance of Circulating Tumor Cells in Non-Small-Cell Lung Cancer Patients: A Meta-AnalysisPLOS ONE, 2013
- Preoperative Platelet Count Associates with Survival and Distant Metastasis in Surgically Resected Colorectal Cancer PatientsJournal of Gastrointestinal Cancer, 2013
- Platelet count predicts prognosis in operable non-small cell lung cancerExperimental and Therapeutic Medicine, 2013
- Clinical and prognostic significance of coagulation assays in lung cancerRespiratory Medicine, 2013
- Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung CancerCancer Research and Treatment, 2012
- Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX studyThe Lancet Oncology, 2011
- Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variablesTherapeutic Advances in Medical Oncology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung CancerBMC Research Notes, 2010
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986